Pay in 4 interest-free payments of $5.93 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Some GLP-1 medications have demonstrated cardiovascular benefits in clinical trials (such as LEADER for liraglutide, SUSTAIN-6 for semaglutide, and REWIND for dulaglutide), and discontinuation may result in loss of these protective effects
The slowdown is particularly dramatic when someone first starts on a GLP-1, which is why they may be particularly sensitive to nausea from high-fat foods during this period
Both versions work, so it just depends on what fits into your life and how fast you want to get started
What we therefore need is a medication that helps make glucose control easier and reduces the risk of obesity and the associated cardiovascular risk
US$ 26.13
US$ 28.42
